GSK may sell Horlicks to focus on OTC and oral health

The pharmaceuticals firm will take control of Sensodyne and Panadol from joint venture partner Novartis.

Comments

Popular posts from this blog

Newcastle’s transformation and reconnection testament to Howe’s coaching | Andy Brassell

Manchester City’s Gabriel Jesus ‘takes it personally’ when he fails in front of goal

Photos: Severe hunger drives IDPs in Kukawa, Borno into begging